Cost Effectiveness of Sorafenib for Treatment of Advanced Hepatocellular Carcinoma in India

ConclusionsSorafenib is not cost-effective for use in advanced hepatocellular carcinoma treatment in India.
Source: Journal of Clinical and Experimental Hepatology - Category: Gastroenterology Source Type: research